Stockscreener 앱 받기
20.74
4.29%
-0.93
전일 마감가:
$21.67
열려 있는:
$21.89
하루 거래량:
157.63K
Relative Volume:
0.89
시가총액:
$1.85B
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-1.85%
1개월 성능:
-5.86%
6개월 성능:
+0.00%
1년 성능:
+0.00%
1일 변동 폭
$20.60
$22.11
1주일 범위
$20.60
$24.76
52주 변동 폭
$19.83
$27.00
Kardigan Inc Stock (KARD) Company Profile
Compare KARD vs VRTX, REGN, ARGX, RVMD, ALNY
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
KARD
Kardigan Inc
|
20.74 | 1.85B | 0 | 0 | 0 | 0.00 |
VRTX
Vertex Pharmaceuticals Inc
|
477.36 | 121.16B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
656.01 | 68.78B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
918.22 | 57.44B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
189.23 | 40.23B | 742.00K | -1.37B | -1.07B | -7.0731 |
ALNY
Alnylam Pharmaceuticals Inc
|
271.77 | 36.28B | 4.29B | 577.22M | 641.34M | 4.2086 |
Kardigan Inc 주식(KARD)의 최신 뉴스
Price to earnings ratio of Kardigan, Inc. – NASDAQ:KARD - TradingView
Price to earnings ratio of Kardigan, Inc. – BOATS:KARD - TradingView
Kardigan, Inc. (NASDAQ:KARD) Short Interest Up ∞ in June - MarketBeat
Hrtg Pv, L.p. Net Worth (2026) - GuruFocus
Kevin Anthony Kelly Net Worth (2026) - GuruFocus
Schf Cif 2024, L.p. Net Worth (2026) - GuruFocus
Keith Bryon Johnson Net Worth (2026) - GuruFocus
Kardigan, Inc.: Target Price Consensus and Analysts Recommendations | KARD | US4859251013 - marketscreener.com
Kardigan, Inc.: Revenue and Earnings Analysts Forecasts Revisions | KARD | US4859251013 - marketscreener.com
Kardigan (KARD) grants 20,706 RSUs tied to Perceptive-linked director pay - Stock Titan
KARD Initiated Coverage by TD Cowen -- Price Target Announced at $46 - GuruFocus
KARD News & Events - Intellectia AI
TD Cowen initiates Kardigan stock with buy rating on cardiology pipeline - Investing.com UK
KARD Initiated Coverage by Leerink Partners -- Rating Outperform - GuruFocus
Kardigan (KARD) Stock Forecast and Price Target 2026 $KARD - MarketBeat
Jefferies initiates Kardigan stock with buy rating on cardiology pipeline By Investing.com - Investing.com Nigeria
KARD Initiated Coverage by JP Morgan -- Price Target Set at $51. - GuruFocus
This Fastenal Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga
Jefferies Initiates Kardigan at Buy With $40 Price Target - marketscreener.com
TD Cowen Initiates Kardigan(KARD.US) With Buy Rating, Announces Target Price $46 - Moomoo
TD Cowen initiates Kardigan stock with buy rating on cardiology pipeline By Investing.com - Investing.com India
JPMorgan initiates Kardigan stock with overweight on pipeline By Investing.com - Investing.com Nigeria
JPMorgan initiates Kardigan stock with overweight on pipeline - Investing.com UK
Jefferies initiates Kardigan stock with buy rating on cardiology pipeline - Investing.com
Kardigan, Inc. Common Stock (NASDAQ: KARD) Share Price, KARD Stock News, KARD Share Price & Updates - Kalkine
CapEx per share of Kardigan, Inc. – NASDAQ:KARD - TradingView
Total common shares outstanding of Kardigan, Inc. – NASDAQ:KARD - TradingView
Average basic shares outstanding of Kardigan, Inc. – BOATS:KARD - TradingView
Kardigan, Inc. Balance Sheet – BOATS:KARD - TradingView
Equity in earnings of Kardigan, Inc. – NASDAQ:KARD - TradingView
EBIT of Kardigan, Inc. – NASDAQ:KARD - TradingView
Price to earnings forward of Kardigan, Inc. – NASDAQ:KARD - TradingView
Price to sales forward of Kardigan, Inc. – NASDAQ:KARD - TradingView
Kardigan, Inc. Financial Statements – NASDAQ:KARD - TradingView
Enterprise value to revenue forward of Kardigan, Inc. – NASDAQ:KARD - TradingView
Enterprise value to EBITDA ratio of Kardigan, Inc. – NASDAQ:KARD - TradingView
EBITDA of Kardigan, Inc. – NASDAQ:KARD - TradingView
Basic earnings per share (basic EPS) of Kardigan, Inc. – NASDAQ:KARD - TradingView
Kardigan (KARD) Revenue BreakdownMain Composition - Moomoo
HRTG GPE, LLC Acquires Significant Stake in Kardigan Inc - GuruFocus
Kardigan (KARD) Stock Analysis Report | Financials & Insights - Benzinga
KARD Price History for Kardigan Stock - Barchart.com
KARDKardigan Inc Volatility & Greeks - Finviz
Latham Advises on Kardigan’s US$460 Million IPO - Legal Desire Media and Insights
HRTG entities report 16.9M shares in Kardigan (KARD) — 18.2% stake - Stock Titan
Kardigan (KARD) backer ARCH discloses 16.2% ownership stake post-IPO - Stock Titan
ARCH Venture Fund XIII Discloses Investment in Kardigan with 16.2% Stake - TradingView
We've developed a first-of-its-kind medicine to battle cardiovascular disease: Kardigan CEO - AOL.com
Kardigan (KARD) Stock Trends and Sentiment 2026 $KARD - MarketBeat
Perceptive Advisors’ Kardigan (KARD) stake tops 8% with IPO lock-up - Stock Titan
Kardigan(KARD) Stock Options Chain | Quotes & News - Moomoo
Kardigan Inc (KARD) 재무 분석
Kardigan Inc (KARD)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
Kardigan Inc 주식 (KARD) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| BERNS PAUL L | Director |
Jun 22 '26 |
Buy |
16.00 |
1,250,000 |
20,000,000 |
15,042,035 |
| ARCH Venture Partners XIII, LL | Director |
Jun 22 '26 |
Buy |
16.00 |
1,250,000 |
20,000,000 |
15,042,035 |
0.46%
0.84%
자본화:
|
볼륨(24시간):